Search
for
Sort by
Research 91–120 of 1000+
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Effects of local and systemic medications on eye health: Adverse reactions
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- Acupuncture for treating alopecia areata: A systematic review and meta-analysis
- Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Comparison of Different Alpha-blocker Combinations in Male Hypertensives with Refractory Lower Urinary Tract Symptoms
- Drug Survival and Long-term Outcome of Tofacitinib in Patients with Alopecia Areata: A Retrospective Study
- Factors predicting response to oral methylprednisolone tapering treatment in alopecia areata: A retrospective study
- Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?
- Effects of 5-alpha reductase inhibitors
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Adverse Effects of 5-Alpha-Reductase Inhibitors: a narrative review
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Adverse health effects of androgen use
- Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy: A Review of Prevalence
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Efectos adversos asociados al uso de anabolizantes en deportistas: revisión sistemática
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- 133 Female Post-Finasteride Syndrome: It’s Not Just A Man’s World
- Cardiovascular risk markers in premature canities
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Guidelines for the Use of Acitretin in Psoriasis
- Hormone therapy for transgender patients
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects